Price (delayed)
$6.91
Market cap
$262.26M
P/E Ratio
8.53
Dividend/share
N/A
EPS
$0.81
Enterprise value
$247.47M
Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody,
There are no recent dividends present for TRDA.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.